Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us
About
Not Confirmed
Not Confirmed
24-26 June, 2025
Not Confirmed
Not Confirmed
23-25 May, 2025
Not Confirmed
Not Confirmed
26-27 May, 2025
List your booth number for exhibitions, ask us
CONTACT DETAILS
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
Industry Trade Show
Not Confirmed
24-26 June, 2025
Industry Trade Show
Not Confirmed
23-25 May, 2025
Industry Trade Show
Not Confirmed
26-27 May, 2025
Digital content
INTERVIEW #SpeakPharma
[Sponsored by another company]https://www.pharmacompass.com/speak-pharma/alchem-nicselect-grants-customers-royalty-free-access-to-t-max-tech-for-3-in-1-vape-satisfaction-in-flavour-restricted-markets
VLOG #PharmaReel
[Sponsored by another company]DATA COMPILATION #PharmaFlow
[Sponsored by another company]https://www.pharmacompass.com/radio-compass-blog/us-drug-shortages-reduce-16-yoy-in-q1-2025-cns-drugs-antimicrobials-face-highest-scarcities
https://www.prnewswire.com/news-releases/nature-paper-from-pact-pharma-and-ucla-highlights-how-patients-with-cancer-respond-differently-to-anti-pd-1-therapy-301765945.html
15 Nov 2022
// Helen Floersh FIERCEBIOTECH
https://www.fiercebiotech.com/research/pact-pharma-establishes-safety-complex-crispr-t-cell-receptor-therapy
02 Nov 2022
// PRNEWSWIRE
https://www.prnewswire.com/news-releases/pact-pharma-to-present-new-data-highlighting-first-of-its-kind-personalized-neoantigen-tcr-t-cell-therapy-platform-at-sitc-2022-301665733.html
03 Oct 2022
// BIOSPACE
https://www.biospace.com/article/releases/pact-pharma-announces-agreement-to-sell-select-assets-to-amplifybio/?s=79
03 Oct 2022
// Max Bayer FIERCEBIOTECH
https://www.fiercebiotech.com/biotech/pact-unveils-teased-bd-venture-sells-select-assets-and-south-san-francisco-facility
25 Aug 2022
// Max Bayer FIERCEBIOTECH
https://www.fiercebiotech.com/biotech/fractured-pact-pharma-lays-additional-51-staffers-suspends-phase-1-trial-company-struggles
ABOUT THIS PAGE